Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Pulmonary Hypertension, July 2019

Free Subscription


Abstracts

Retrieve all available abstracts of the following 130 articles:
HTML format


 

Single Articles

  1. MASDING A, Preston SD, Toshner M, Barnett J, et al
    Chronic thromboembolic pulmonary hypertension following long-term peripherally inserted central venous catheter use.
    Pulm Circ. 2019;9:2045894019859474.
    Abstract    

    Abstract available

  2. MARTINEZ C, Sugimoto T, Tsugu T, Oury C, et al
    Novel non-pharmacological therapy to modulate the autonomic tone in patients with heart failure with pulmonary hypertension.
    J Thorac Dis. 2019;11.
    Abstract    



  3. JIN H, Jiang Y, Du F, Guo L, et al
    Isoliquiritigenin Attenuates Monocrotaline-Induced Pulmonary Hypertension via Inhibition of the Inflammatory Response and PASMCs Proliferation.
    Evid Based Complement Alternat Med. 2019;2019:4568198.
    Abstract    

    Abstract available

  4. PILKA M, Darocha S, Banaszkiewicz M, Florczyk M, et al
    The evolution of electrocardiographic signs of right ventricular overload after balloon pulmonary angioplasty in chronic thromboembolic pulmonary hypertension.
    Pol Arch Intern Med. 2019 Jun 25. doi: 10.20452/pamw.14877.
    Abstract    

    Abstract available

  5. DESER SB
    Acute pulmonary artery dissection with aneurysm without pulmonary hypertension.
    J Card Surg. 2019 Jun 24. doi: 10.1111/jocs.14122.
    Abstract    



  6. ZOPPELLARO G, Badawy MR, Squizzato A, Denas G, et al
    Balloon Pulmonary Angioplasty in Patients With Chronic Thromboembolic Pulmonary Hypertension- A Systematic Review and Meta-Analysis.
    Circ J. 2019 Jun 21. doi: 10.1253/circj.CJ-19-0161.
    Abstract    

    Abstract available

  7. SANAMPUDI S, Bartolome S, Kalva S
    Balloon Pulmonary Angioplasty for Chronic Thromboembolic Pulmonary Hypertension.
    J Vasc Interv Radiol. 2019;30:1081.
    Abstract    



  8. CHAZOVA IE, Arkhipova OA, Martynyuk TV
    Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry.
    Ter Arkh. 2019;91:24-31.
    Abstract    

    Abstract available

  9. GUIOT J, Parzibut G, Weber T, Davin L, et al
    [Pulmonary arterial hypertension].
    Rev Med Liege. 2019;74:139-145.
    Abstract    

    Abstract available

  10. ZURLO G, Piquereau J, Moulin M, Pires Da Silva J, et al
    Sirtuin 1 regulates pulmonary artery smooth muscle cell proliferation: role in pulmonary arterial hypertension.
    J Hypertens. 2018 Jan 24. doi: 10.1097/HJH.0000000000001676.
    Abstract    

    Abstract available

  11. ROSENKRANZ S, Diller GP, Dumitrescu D, Ewert R, et al
    [Hemodynamic Definition of Pulmonary Hypertension: Commentary on the Proposed Change by the 6th World Symposium on Pulmonary Hypertension].
    Dtsch Med Wochenschr. 2019 Jul 5. doi: 10.1055/a-0918-3772.
    Abstract    

    Abstract available

  12. EL-DABH A, Acharya D
    EXPRESS: Pulmonary hypertension with dasatinib and other tyrosine kinase inhibitors.
    Pulm Circ. 2019 Jul 5:2045894019865704. doi: 10.1177/2045894019865704.
    Abstract    



  13. MASRI A, Gleason TG, Lee JS, Cavalcante JL, et al
    Pulmonary Hypertension Persistency in Severe Aortic Stenosis Patients Treated With TAVR.
    JACC Cardiovasc Imaging. 2019;12.
    Abstract    



  14. PATEL MD, Breatnach CR, James AT, Choudhry S, et al
    Echocardiographic Assessment of Right Ventricular Afterload in Preterm Infants: Maturational Patterns of Pulmonary Artery Acceleration Time Over the First Year of Age and Implications for Pulmonary Hypertension.
    J Am Soc Echocardiogr. 2019;32:884-894.
    Abstract    

    Abstract available

  15. LIU BY, Wu WC, Zeng QX, Liu ZH, et al
    EXPRESS: Left ventricular early diastolic strain rate detected by two-dimensional speckle tracking echocardiography and disease severity in pre-capillary pulmonary hypertension.
    Pulm Circ. 2019 Jul 3:2045894019865158. doi: 10.1177/2045894019865158.
    Abstract    



  16. GUO J, Yang ZC, Liu Y
    Attenuating Pulmonary Hypertension by Protecting the Integrity of Glycocalyx in Rats Model of Pulmonary Artery Hypertension.
    Inflammation. 2019 Jul 2. pii: 10.1007/s10753-019-01055.
    Abstract    

    Abstract available

  17. SYDYKOV A, Muratali Uulu K, Maripov A, Cholponbaeva M, et al
    A Case of Chronic Thromboembolic Pulmonary Hypertension in a High-Altitude Dweller.
    High Alt Med Biol. 2019 Jul 2. doi: 10.1089/ham.2018.0132.
    Abstract    

    Abstract available

  18. AUSTIN M, Quesenberry PJ, Ventetuolo CE, Liang O, et al
    Prevalence and Effect on Survival of Pulmonary Hypertension in Myelofibrosis.
    Clin Lymphoma Myeloma Leuk. 2019 May 13. pii: S2152-2650(19)30110.
    Abstract    

    Abstract available

  19. NITZAN I, Kasirer Y, Mimouni FB, Fink D, et al
    Elevated Nucleated Red Blood Cells in Neonates with Down Syndrome and Pulmonary Hypertension.
    J Pediatr. 2019 Jun 28. pii: S0022-3476(19)30685.
    Abstract    

    Abstract available

  20. AKIZUKI M, Sugimura K, Aoki T, Kakihana T, et al
    Non-invasive screening using ventilatory gas analysis to distinguish between chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension.
    Respirology. 2019 Jul 1. doi: 10.1111/resp.13618.
    Abstract    

    Abstract available

  21. PATTNAIK P, Levin T, Gagne S, Angert R, et al
    Case 2: Rapidly Growing Neck Mass in an Extremely Preterm Infant with Pulmonary Hypertension.
    Neoreviews. 2019;20:e226-e228.
    Abstract    



  22. MICKAEL C, Kumar R, Hernandez-Saavedra D, Kassa B, et al
    IL-6Ra in Smooth Muscle Cells Protects against Schistosoma- and Hypoxia-induced Pulmonary Hypertension.
    Am J Respir Cell Mol Biol. 2019;61:123-126.
    Abstract    



  23. SAWADA N, Kawata T, Daimon M, Nakao T, et al
    Detection of Pulmonary Hypertension with Systolic Pressure Estimated by Doppler Echocardiography.
    Int Heart J. 2019 Jun 28. doi: 10.1536.
    Abstract    

    Abstract available

  24. HOU J, Liu B, Zhu B, Wang D, et al
    Role of integrin-linked kinase in the hypoxia-induced phenotypic transition of pulmonary artery smooth muscle cells: Implications for hypoxic pulmonary hypertension.
    Exp Cell Res. 2019 Jun 27. pii: S0014-4827(19)30316.
    Abstract    

    Abstract available

  25. MURGIER M, Forest F, Savale L, Ilie M, et al
    Pulmonary hypertension due to pulmonary artery obstructions by malignant tumoral cells.
    Respir Med Res. 2019;76:10-12.
    Abstract    



  26. MACHIDA A, Soejima I, Bo T, Amano E, et al
    Paradoxical Cerebral Embolism as Initial Manifestation of Chronic Thromboembolic Pulmonary Hypertension: A Case Report.
    J Stroke Cerebrovasc Dis. 2019 Jun 25. pii: S1052-3057(19)30275.
    Abstract    

    Abstract available

  27. FINGROVA Z, Havranek S, Ambroz D, Jansa P, et al
    The left atrial substrate plays a significant role in the development of complex atrial tachycardia in patients with precapillary pulmonary hypertension.
    BMC Cardiovasc Disord. 2019;19:157.
    Abstract    

    Abstract available

  28. KEMDEM A, Lemaitre F, Lovat R, Siraux V, et al
    Acute hypoxic pulmonary hypertension associated with right heart failure.
    Acta Cardiol. 2019 Jun 28:1-5. doi: 10.1080/00015385.2019.1634333.
    Abstract    

    Abstract available

  29. CHANG WT
    Smoking May Contribute to an Increase of miR-21 and a Worse Outcome in Pulmonary Hypertension.
    Acta Cardiol Sin. 2019;35:350.
    Abstract    



  30. KOSANOVIC D, Deo U, Gall H, Selvakumar B, et al
    EXPRESS: Enhanced circulating levels of CD3 cells-derived extracellular vesicles in different forms of pulmonary hypertension.
    Pulm Circ. 2019 Jun 28:2045894019864357. doi: 10.1177/2045894019864357.
    Abstract    



  31. KERN MJ, Kim M, Yu J, Seto AH, et al
    Evaluation of the severity of mitral stenosis in patient with pulmonary hypertension: Role of exercise hemodynamics.
    Catheter Cardiovasc Interv. 2019 Jun 27. doi: 10.1002/ccd.28381.
    Abstract    

    Abstract available

  32. CONDON DF, Nickel NP, Anderson R, Mirza S, et al
    The 6th World Symposium on Pulmonary Hypertension: what's old is new.
    F1000Res. 2019;8.
    Abstract    

    Abstract available

  33. ZIYA SENER Y, Oksul M, Hekimsoy V
    Smoking Has Effects on MicroRNAs and Pulmonary Hypertension.
    Acta Cardiol Sin. 2019;35:349.
    Abstract    



  34. GULER E, Narin N, Pamukcu O, Taheri S, et al
    Can microsomal RNA be a biomarker in pulmonary hypertension secondary to bronchopulmonary dysplasia?
    J Matern Fetal Neonatal Med. 2019.
    Abstract    

    Abstract available

  35. CHAZOVA IE, Martynyuk TV
    Expert Council resolution on pulmonary arterial hypertension (PAH) "Changing the paradigm of treating patients with pulmonary arterial hypertension".
    Ter Arkh. 2019;91:114-116.
    Abstract    



  36. MARON BA
    Back to the Future: Building Up the Case for Exploring Red Blood Cell Morphology in Pulmonary Arterial Hypertension.
    Ann Am Thorac Soc. 2019;16:548-550.
    Abstract    



  37. ALRDDADI SM, Morsy MM, Albakri JK, Mohammed MA, et al
    Risk factors for prolonged mechanical ventilation after surgical repair of congenital heart disease. Experience from a single cardiac center.
    Saudi Med J. 2019;40:367-371.
    Abstract    

    Abstract available

  38. HAMID R, Austin ED
    End Stage Takes Center Stage in Pulmonary Arterial Hypertension.
    Am J Respir Cell Mol Biol. 2019;60:607-608.
    Abstract    



  39. LEVINE AR, Bain W, Bednash JS, Gladwin MT, et al
    AMP Kinase Activation Attenuates Cardiac Remodeling in Pulmonary Hypertension due to Heart Failure with Preserved Ejection Fraction; Lung Epithelial Progenitor Cells in Alveolar Regeneration; and Drug Discovery and Novel Therapies for Lung Cancer.
    Am J Respir Cell Mol Biol. 2019;60:244-247.
    Abstract    



  40. FURUKAWA T, Matsui K, Kitano M, Yokoyama Y, et al
    Relationship between YKL-40 and pulmonary arterial hypertension in systemic sclerosis.
    Mod Rheumatol. 2019;29:476-483.
    Abstract    

    Abstract available

  41. SONTI R, Gersten RA, Barnett S, Brown AW, et al
    Multimodal Noninvasive Prediction of Pulmonary Hypertension in IPF.
    Clin Respir J. 2019 Jul 13. doi: 10.1111/crj.13059.
    Abstract    

    Abstract available

  42. KRUTHIVENTI SC, Kane GC, Sprung J, Weingarten TN, et al
    Postoperative pulmonary complications in contemporary cohort of patients with pulmonary hypertension.
    Bosn J Basic Med Sci. 2019 Jul 3. doi: 10.17305/bjbms.2019.4332.
    Abstract    

    Abstract available

  43. ORDONEZ DIOS IM, Rienda Moreno MA, Lazaro Polo J
    Right Lung Agenesis Associated with Dextrocardia and Pulmonary Hypertension.
    Arch Bronconeumol. 2019 Jul 9. pii: S0300-2896(19)30280.
    Abstract    



  44. CORTES-PUCH I, Sun J, Schecter AN, Solomon SB, et al
    Inhaled nebulized nitrite and nitrate therapy in a canine model of hypoxia-induced pulmonary hypertension.
    Nitric Oxide. 2019 Jul 9. pii: S1089-8603(19)30114.
    Abstract    

    Abstract available

  45. ALEBNA PA, Kim DH, Chaudhary R, Tavares M, et al
    Pulmonary hypertension and congenital bronchial atresia: A time factor association.
    Respir Med Case Rep. 2019;28:100882.
    Abstract    

    Abstract available

  46. LI Q, Li H, Shi J, He B, et al
    Complement alternative pathway activation associated with pulmonary hypertension in lupus nephritis patients.
    Lupus. 2019 Jul 11:961203319860192. doi: 10.1177/0961203319860192.
    Abstract    

    Abstract available

  47. BUSH D, Wolter-Warmerdam K, Wagner BD, Galambos C, et al
    EXPRESS: Angiogenic Profile Identifies Pulmonary Hypertension in Children with Down Syndrome.
    Pulm Circ. 2019 Jul 11:2045894019866549. doi: 10.1177/2045894019866549.
    Abstract    



  48. RAO SD, Menachem JN, Birati EY, Mazurek JA, et al
    Pulmonary Hypertension in Advanced Heart Failure: Assessment and Management of the Failing RV and LV.
    Curr Heart Fail Rep. 2019 Jul 10. pii: 10.1007/s11897-019-00431.
    Abstract    

    Abstract available

  49. MIYASAKA A, Yoshida Y, Suzuki A, Ueda H, et al
    A case of suspected portal-pulmonary hypertension due to hepatitis C virus infection.
    Clin J Gastroenterol. 2019 Jul 10. pii: 10.1007/s12328-019-01016.
    Abstract    

    Abstract available

  50. LIU J, Nahrwold DA, Serdiuk AA, Koontz DB, et al
    Intraoperative Goal-Directed Anesthetic Management of the Patient with Severe Pulmonary Hypertension.
    Am J Case Rep. 2019;20:998-1001.
    Abstract    

    Abstract available

  51. KURATH-KOLLER S, Avian A, Cantinotti M, Burmas A, et al
    Normal Pediatric Values of the Subcostal Tricuspid Annular Plane Systolic Excursion (S-TAPSE) and Its Value in Pediatric Pulmonary Hypertension.
    Can J Cardiol. 2019;35:899-906.
    Abstract    

    Abstract available

  52. BABU AS, Padmakumar R, Nayak K, Shetty R, et al
    Effects of home-based exercise training on functional outcomes and quality of life in patients with pulmonary hypertension: A randomized clinical trial.
    Indian Heart J. 2019;71:161-165.
    Abstract    

    Abstract available

  53. LIU C, Cheng P, Liu A, Li B, et al
    Reverse Remodeling of Pulmonary Arterioles After Pulmonary Artery Banding in Patients >/= 2 Years Old with Severe Pulmonary Arterial Hypertension and Congenital Heart Disease.
    Pediatr Cardiol. 2019;40:958-964.
    Abstract    

    Abstract available

  54. ONG MS
    A Bayesian Network Approach to Disease Subtype Discovery.
    Methods Mol Biol. 2019;1939:299-322.
    Abstract    

    Abstract available

  55. TATEISHI A, Nakashima K, Hoshi K, Oyama Y, et al
    Pulmonary Tumor Thrombotic Microangiopathy Mimicking Inhalation Lung Injury.
    Intern Med. 2019;58:1311-1314.
    Abstract    

    Abstract available

  56. WACKER J, Weintraub R, Beghetti M
    An update on current and emerging treatments for pulmonary arterial hypertension in childhood and adolescence.
    Expert Rev Respir Med. 2019;13:205-215.
    Abstract    

    Abstract available

  57. LINECKER M, Krones T, Berg T, Niemann CU, et al
    Potentially Inappropriate Liver Transplantation in the Era of the "Sickest-first" Policy - A Search for the Upper Limits.
    J Hepatol. 2017 Nov 10. pii: S0168-8278(17)32430.
    Abstract    

    Abstract available

  58. DAS BB, Jadotte MM, Chan KC
    Pulmonary Vascular Underperfusion Score in Premature Infants with Bronchopulmonary Dysplasia and Pulmonary Hypertension.
    Medicina (Kaunas). 2019;55.
    Abstract    

    Abstract available

  59. LI Q, Zhou X, Zhou X
    Downregulation of miR98 contributes to hypoxic pulmonary hypertension by targeting ALK1.
    Mol Med Rep. 2019 Jul 9. doi: 10.3892/mmr.2019.10482.
    Abstract    

    Abstract available

  60. GAYNITDINOVA VV, Avdeev SN
    [Novel Biomarkers of Pulmonary Hypertension].
    Kardiologiia. 2019;59:84-94.
    Abstract    

    Abstract available

  61. ROSENKRANZ S, Kramer T, Gerhardt F, Opitz C, et al
    Pulmonary hypertension in HFpEF and HFrEF: Pathophysiology, diagnosis, treatment approaches.
    Herz. 2019 Jul 17. pii: 10.1007/s00059-019-4831.
    Abstract    

    Abstract available

  62. CARVALHO CG, Bresler R, Zhi YX, Alshaer H, et al
    Heart rate variability in pulmonary hypertension with and without sleep apnea.
    Heliyon. 2019;5:e02034.
    Abstract    

    Abstract available

  63. LI Y, Yang L, Dong L, Yang ZW, et al
    Crosstalk between the Akt/mTORC1 and NF-kappaB signaling pathways promotes hypoxia-induced pulmonary hypertension by increasing DPP4 expression in PASMCs.
    Acta Pharmacol Sin. 2019 Jul 17. pii: 10.1038/s41401-019-0272.
    Abstract    

    Abstract available

  64. TICHELBACKER T, Dumitrescu D, Gerhardt F, Stern D, et al
    Pulmonary hypertension and valvular heart disease.
    Herz. 2019 Jul 16. pii: 10.1007/s00059-019-4823.
    Abstract    

    Abstract available

  65. KAROLAK JA, Szafranski P, Kilner D, Patel C, et al
    Heterozygous CTNNB1 and TBX4 variants in a patient with abnormal lung growth, pulmonary hypertension, microcephaly, and spasticity.
    Clin Genet. 2019 Jul 16. doi: 10.1111/cge.13605.
    Abstract    

    Abstract available

  66. INAMPUDI C, Hemnes AR, Briasoulis A
    Approach to a patient with pulmonary hypertension.
    J Geriatr Cardiol. 2019;16:478-481.
    Abstract    

    Abstract available

  67. ANDERSEN S, Axelsen JB, Ringgaard S, Nyengaard JR, et al
    Effects of combined angiotensin II receptor antagonism and neprilysin inhibition in experimental pulmonary hypertension and right ventricular failure.
    Int J Cardiol. 2019 Jun 29. pii: S0167-5273(19)30876.
    Abstract    

    Abstract available

  68. DARDAS TF
    Pulmonary Hypertension Associated with Heart Failure: A challenge of prediction or persistence?
    J Card Fail. 2019 Jul 12. pii: S1071-9164(19)30728.
    Abstract    



  69. STOBDAN T, Haddad GG
    Commentary: Novel Insight into the Genetic Basis of High Altitude Pulmonary Hypertension in Kyrgyz Highlanders.
    J Lung Health Dis. 2019;3:29-30.
    Abstract    



  70. PEARCE B, Hu R, Desmond F, Banyasz D, et al
    Intraoperative TOE guided management of newly diagnosed severe tricuspid regurgitation and pulmonary hypertension during orthotopic liver transplantation: a case report demonstrating the importance of reversibility as a favorable prognostic factor.
    BMC Anesthesiol. 2019;19:128.
    Abstract    

    Abstract available

  71. CHENG CC, Chi PL, Shen MC, Shu CW, et al
    Caffeic Acid Phenethyl Ester Rescues Pulmonary Arterial Hypertension through the Inhibition of AKT/ERK-Dependent PDGF/HIF-1alpha In Vitro and In Vivo.
    Int J Mol Sci. 2019;20.
    Abstract    

    Abstract available

  72. MAEDA NY, Aiello VD, Santos PC, Thomaz AM, et al
    Relation of Macrophage Migration Inhibitory Factor to Pulmonary Hemodynamics and Vascular Structure and Carbamyl-Phosphate Synthetase I Genetic Variations in Pediatric Patients with Congenital Cardiac Shunts.
    Mediators Inflamm. 2019;2019:7305028.
    Abstract    

    Abstract available

  73. ZHANG Q, Zucco L, Toshner M, Morrell NW, et al
    Myeloid angiogenic cells exhibit impaired migration, reduced expression of endothelial markers, and increased apoptosis in idiopathic pulmonary arterial hypertension (1).
    Can J Physiol Pharmacol. 2019;97:306-312.
    Abstract    

    Abstract available

  74. DEL POZO R, Blanco I, Hernandez-Gonzalez I, Lopez-Meseguer M, et al
    Real-life experience of inhaled iloprost for patients with pulmonary arterial hypertension: Insights from the Spanish REHAP registry.
    Int J Cardiol. 2019;275:158-164.
    Abstract    

    Abstract available

  75. XIAOLU W, Yunliang G
    Letter by Wang and Guo regarding article Long non-coding RNA and mRNA profile analysis of metformin to reverse the pulmonary hypertension vascular remodeling induced by monocrotaline.
    Biomed Pharmacother. 2019;118:109238.
    Abstract    



  76. ZHAO JH, He YY, Guo SS, Yan Y, et al
    Circulating Plasma Metabolomic Profiles Differentiate Rodent Models of Pulmonary Hypertension and Idiopathic Pulmonary Arterial Hypertension Patients.
    Am J Hypertens. 2019 Jul 27. pii: 5539701. doi: 10.1093.
    Abstract    

    Abstract available

  77. AKIZUKI M, Sugimura K, Aoki T, Kakihana T, et al
    Usefulness of ventilatory gas analysis for the non-invasive evaluation of the severity of chronic thromboembolic pulmonary hypertension.
    Int J Cardiol. 2019 Jul 8. pii: S0167-5273(19)30008.
    Abstract    

    Abstract available

  78. GODINAS L, Bonne L, Budts W, Belge C, et al
    Balloon Pulmonary Angioplasty for the Treatment of Nonoperable Chronic Thromboembolic Pulmonary Hypertension: Single-Center Experience with Low Initial Complication Rate.
    J Vasc Interv Radiol. 2019;30:1265-1272.
    Abstract    

    Abstract available

  79. KIDO K, Coons JC
    Efficacy and Safety of the Use of Pulmonary Arterial Hypertension Pharmacotherapy in Patients with Pulmonary Hypertension Secondary to Left Heart Disease: A Systematic Review.
    Pharmacotherapy. 2019 Jul 26. doi: 10.1002/phar.2314.
    Abstract    

    Abstract available

  80. GENTLE SJ, Abman SH, Ambalavanan N
    Oxygen Therapy and Pulmonary Hypertension in Preterm Infants.
    Clin Perinatol. 2019;46:611-619.
    Abstract    

    Abstract available

  81. SEPULVEDA P, Ortega J, Armijo G, Torres J, et al
    [Balloon pulmonary angioplasty for the treatment of chronic thromboembolic pulmonary hypertension].
    Rev Med Chil. 2019;147:426-436.
    Abstract    

    Abstract available

  82. TSAI CH, Ma HP, Lin YT, Hung CS, et al
    Heart Rhythm Complexity Impairment in Patients with Pulmonary Hypertension.
    Sci Rep. 2019;9:10710.
    Abstract    

    Abstract available

  83. VERBELEN T
    Tackling the right ventricle in chronic thromboembolic pulmonary hypertension.
    J Physiol. 2019 Jul 24. doi: 10.1113/JP278448.
    Abstract    



  84. PUENTE UBIERNA N, Bachiller Carnicero L, Corredera Sanchez A, Martinez Orgado JA, et al
    [Prostaglandin 12 analogs (epoprostenol and treprostinil) as a treatment for refractory bronchopulmonary dysplasia-induced pulmonary hypertension in an infant].
    Arch Argent Pediatr. 2019;117:e413-e415.
    Abstract    

    Abstract available

  85. KUMAR R, Mickael C, Kassa B, Sanders L, et al
    Th2 CD4(+) T Cells Are Necessary and Sufficient for Schistosoma-Pulmonary Hypertension.
    J Am Heart Assoc. 2019;8:e013111.
    Abstract    

    Abstract available

  86. RADIK M, Kmecova Z, Veteskova J, Malikova E, et al
    Hepatocyte growth factor plays a particular role in progression of overall cardiac damage in experimental pulmonary hypertension.
    Int J Med Sci. 2019;16:854-863.
    Abstract    

    Abstract available

  87. YAMAMOTO K, Nishimura R, Kato F, Naito A, et al
    Protective role of endothelial progenitor cells stimulated by riociguat in chronic thromboembolic pulmonary hypertension.
    Int J Cardiol. 2019 Jul 15. pii: S0167-5273(19)30981.
    Abstract    

    Abstract available

  88. PERROS F, Sentenac P, Boulate D, Manaud G, et al
    Smooth Muscle Phenotype in Idiopathic Pulmonary Hypertension: Hyper-Proliferative but not Cancerous.
    Int J Mol Sci. 2019;20.
    Abstract    

    Abstract available

  89. PICH J
    Phosphodiesterase 5 inhibitors for pulmonary hypertension.
    Int J Evid Based Healthc. 2019 Jul 22. doi: 10.1097/XEB.0000000000000198.
    Abstract    



  90. BOTONI FA, Marinho CC, Carvalho VT, Mickael CS, et al
    A retrospective study of schistosomiasis-associated pulmonary hypertension from an endemic area in Brazil.
    Int J Cardiol Heart Vasc. 2019;24:100387.
    Abstract    



  91. GOOBIE GC, Sirrs SM, Yee J, English JC, et al
    Lessons from lung transplantation: Cause for redefining the pathophysiology of pulmonary hypertension in gaucher disease.
    Respir Med Case Rep. 2019;28:100893.
    Abstract    

    Abstract available

  92. PEREGUD-POGORZELSKA M, Lewandowski M, Trzcinska-Butkiewicz B, Brzosko M, et al
    Right atrial myxoma: a potential accelerator of pulmonary hypertension in the course of systemic sclerosis. The role of interleukin-6.
    Postepy Dermatol Alergol. 2019;36:354-357.
    Abstract    



  93. VON VISGER TT, Thrane SE, Klatt MD, Dabbs AD, et al
    Intervention fidelity monitoring of Urban Zen Integrative Therapy (UZIT) for persons with pulmonary hypertension.
    Complement Ther Med. 2019;45:45-49.
    Abstract    

    Abstract available

  94. KOTHARI SS, Relan J, Devagourou V
    Operable ventricular septal defect despite severe pulmonary hypertension and cyanosis!
    Cardiol Young. 2019 Jul 23:1-3. doi: 10.1017/S1047951119001057.
    Abstract    

    Abstract available

  95. CHEN LL, Zmuda EJ, Talavera MM, Frick J, et al
    Dual-specificity phosphatase (DUSP) genetic variants predict pulmonary hypertension in patients with bronchopulmonary dysplasia.
    Pediatr Res. 2019 Jul 22. pii: 10.1038/s41390-019-0502.
    Abstract    

    Abstract available

  96. MIRNA M, Rohm I, Jirak P, Wernly B, et al
    Analysis of Novel Cardiovascular Biomarkers in Patients With Pulmonary Hypertension (PH).
    Heart Lung Circ. 2019 Apr 1. pii: S1443-9506(19)30293.
    Abstract    

    Abstract available

  97. BURGMEIER C, Schier F
    Are Cardiac Anomalies and Persistent Fetal Circulation a Risk Factor for Cardiovascular Events During Minimally Invasive Surgery in Neonates?
    J Laparoendosc Adv Surg Tech A. 2019;29:694-697.
    Abstract    

    Abstract available

  98. WANG L, Wang Y, Lei Z
    Chrysin ameliorates ANTU-induced pulmonary edema and pulmonary arterial hypertension via modulation of VEGF and eNOs.
    J Biochem Mol Toxicol. 2019;33:e22332.
    Abstract    

    Abstract available

  99. BUONAURO A, Sorrentino R, Esposito R, Nappi L, et al
    Three-dimensional echocardiographic evaluation of the right ventricle in patients with uncomplicated systemic lupus erythematosus.
    Lupus. 2019;28:538-544.
    Abstract    

    Abstract available

  100. WANG Y, Yan Y, Zhang J, Li J, et al
    Uveal effusion and transient myopia as the initial presentation of systemic lupus erythematosus patient with pulmonary arterial hypertension: case report.
    Lupus. 2019;28:560-564.
    Abstract    

    Abstract available

  101. SABLINSKIS M, Sablinskis K, Skride A
    Pulmonary Endarterectomy in Latvia: A National Experience.
    Medicina (Kaunas). 2019;55.
    Abstract    

    Abstract available

  102. TIELEMANS B, Delcroix M, Belge C, Quarck R, et al
    TGFbeta and BMPRII signalling pathways in the pathogenesis of pulmonary arterial hypertension.
    Drug Discov Today. 2019;24:703-716.
    Abstract    

    Abstract available

  103. GRASSO C, Popolo Rubbio A, Capodanno D, Buccheri S, et al
    Incidence, Timing, Causes and Predictors of Early and Late Re-Hospitalization in Patients Who Underwent Percutaneous Mitral Valve Repair With the MitraClip System.
    Am J Cardiol. 2018 Feb 12. pii: S0002-9149(18)30193.
    Abstract    

    Abstract available

  104. NIJENHUIS VJ, Peper J, Vorselaars VMM, Swaans MJ, et al
    Prognostic Value of Improved Kidney Function After Transcatheter Aortic Valve Implantation for Aortic Stenosis.
    Am J Cardiol. 2018 Feb 12. pii: S0002-9149(18)30195.
    Abstract    

    Abstract available

  105. LACHANT D, Meoli DF, Haight D, Staicu S, et al
    Combination Therapy Improves Vascular Volume in Female Rats with Pulmonary Hypertension.
    Am J Physiol Lung Cell Mol Physiol. 2019 Jul 19. doi: 10.1152/ajplung.00450.2018
    Abstract    

    Abstract available

  106. BERGER RMF, Beghetti M
    Early Diagnosis in Pulmonary Arterial Hypertension: The Search for the Holy Grail.
    Am J Respir Crit Care Med. 2019;199:1306-1307.
    Abstract    



  107. TOSHNER M
    BMP9 Morphs into a Potential Player in Portopulmonary Hypertension.
    Am J Respir Crit Care Med. 2019;199:819-821.
    Abstract    



  108. HUI DS
    Effect of Pulmonary Hypertension on Clinical Outcomes in Patients with Rheumatic Mitral Stenosis (Commentary).
    Ann Thorac Surg. 2019 Jul 22. pii: S0003-4975(19)31047.
    Abstract    



  109. KIM DJ, Lee S, Joo HC, Lee H, et al
    Effect of Pulmonary Hypertension on Clinical Outcomes in Patients with Rheumatic Mitral Stenosis.
    Ann Thorac Surg. 2019 Jul 20. pii: S0003-4975(19)31043.
    Abstract    

    Abstract available

  110. TUDER RM, Cool CD
    Pulmonary Arteries and Microcirculation in COPD With Pulmonary Hypertension: Bystander or Culprit?
    Chest. 2019;156:4-6.
    Abstract    



  111. LAMBERT M, Capuano V, Boet A, Tesson L, et al
    Characterization of Kcnk3-Mutated Rat, a Novel Model of Pulmonary Hypertension.
    Circ Res. 2019 Jul 26. doi: 10.1161/CIRCRESAHA.119.314793.
    Abstract    

    Abstract available

  112. KONSTAM MA, Kiernan MS, Bernstein D, Bozkurt B, et al
    Evaluation and Management of Right-Sided Heart Failure: A Scientific Statement From the American Heart Association.
    Circulation. 2018 Apr 12. pii: CIR.0000000000000560.
    Abstract    

    Abstract available

  113. DUMAS SJ, Bru-Mercier G, Courboulin A, Quatredeniers M, et al
    NMDA-Type Glutamate Receptor Activation Promotes Vascular Remodeling and Pulmonary Arterial Hypertension.
    Circulation. 2018 Feb 14. pii: CIRCULATIONAHA.117.029930.
    Abstract    

    Abstract available

  114. HSU S, Kokkonen-Simon KM, Kirk JA, Kolb TM, et al
    Right Ventricular Myofilament Functional Differences in Humans with Systemic Sclerosis-associated versus Idiopathic Pulmonary Arterial Hypertension.
    Circulation. 2018 Jan 19. pii: CIRCULATIONAHA.117.033147.
    Abstract    

    Abstract available

  115. KURAKULA K, Sun XQ, Happe C, da Silva Goncalves Bos D, et al
    6-mercaptopurine, an agonist of Nur77, reduces progression of pulmonary hypertension by enhancing BMP signalling.
    Eur Respir J. 2019 Jul 4. pii: 13993003.02400-2018.
    Abstract    

    Abstract available

  116. NAEIJE R
    Pulmonary hypertension at high altitude.
    Eur Respir J. 2019;53.
    Abstract    



  117. THEILMANN AL, Ormiston ML
    Repurposing benzbromarone for pulmonary arterial hypertension: can channelling the past deliver the therapy of the future?
    Eur Respir J. 2019;53.
    Abstract    



  118. BECK EM, Hatton ND, Ryan JJ
    Novel techniques for advancing our understanding of pulmonary arterial hypertension.
    Eur Respir J. 2019;53.
    Abstract    



  119. DE MAN FS, Handoko ML, Vonk-Noordegraaf A
    The unknown pathophysiological relevance of right ventricular hypertrophy in pulmonary arterial hypertension.
    Eur Respir J. 2019;53.
    Abstract    



  120. ABID S, Marcos E, Parpaleix A, Amsellem V, et al
    CCR2/CCR5-Mediated Macrophage-Smooth Muscle Cell Crosstalk in Pulmonary Hypertension.
    Eur Respir J. 2019 Jul 18. pii: 13993003.02308-2018.
    Abstract    

    Abstract available

  121. HUITEMA MP, Bakker ALM, Mager JJ, Rensing BJWM, et al
    Prevalence of pulmonary hypertension in pulmonary sarcoidosis; the first large European prospective study.
    Eur Respir J. 2019 Jul 18. pii: 13993003.00897-2019.
    Abstract    



  122. MCLAUGHLIN VV, Hoeper MM, Channick RN, Chin KM, et al
    Pulmonary Arterial Hypertension-Related Morbidity Is Prognostic for Mortality.
    J Am Coll Cardiol. 2018;71:752-763.
    Abstract    

    Abstract available

  123. KANEMARU E, Yoshitani K, Kato S, Fujii T, et al
    Comparison of Right Ventricular Function Between Patients With and Without Pulmonary Hypertension Owing to Left-Sided Heart Disease: Assessment Based on Right Ventricular Pressure-Volume Curves.
    J Cardiothorac Vasc Anesth. 2019 May 27. pii: S1053-0770(19)30488.
    Abstract    

    Abstract available

  124. SHARMA V, Tempe DK
    The Effect of Inhaled Milrinone Versus Inhaled Levosimendan in Pulmonary Hypertension Patients Undergoing Mitral Valve Surgery.
    J Cardiothorac Vasc Anesth. 2019 Jun 19. pii: S1053-0770(19)30567.
    Abstract    



  125. SARDO S, Osawa EA, Finco G, Gomes Galas FRB, et al
    Nitric Oxide in Cardiac Surgery: A Meta-Analysis of Randomized Controlled Trials.
    J Cardiothorac Vasc Anesth. 2018 Apr 24. pii: S1053-0770(18)30102.
    Abstract    

    Abstract available

  126. ARTHUR ATAAM J, Mercier O, Lamrani L, Amsallem M, et al
    ICAM-1 promotes the abnormal endothelial cell phenotype in chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2019 Jun 19. pii: S1053-2498(19)31552.
    Abstract    

    Abstract available

  127. SINGH A, Feingold B, Rivera-Lebron B, Weiner D, et al
    Correlating objective echocardiographic parameters in patients with pulmonary hypertension due to bronchopulmonary dysplasia.
    J Perinatol. 2019 Jul 16. pii: 10.1038/s41372-019-0429.
    Abstract    

    Abstract available

  128. AL-LAWAMA M
    Letter to the editor: Treatment of patent ductus arteriosus in premature infants.
    J Perinatol. 2018 Mar 7. pii: 10.1038/s41372-018-0085.
    Abstract    



  129. CHENG CH, Wang YC, Wu TH, Lee CF, et al
    Sildenafil Monotherapy to Treat Portopulmonary Hypertension Before Liver Transplant.
    Transplant Proc. 2019 May 9. pii: S0041-1345(18)31809.
    Abstract    

    Abstract available

  130. PISCHKE SE, Hestenes S, Johansen HT, Fure H, et al
    Sepsis causes right ventricular myocardial inflammation independent of pulmonary hypertension in a porcine sepsis model.
    PLoS One. 2019;14:e0218624.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pulmonary Hypertension is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;